ea0059p141 | Neuroendocrinology and pituitary | SFEBES2018
Garrahy Aoife
, Hannon Anne Marie
, Cuesta Martin
, Murphy Bryan
, Tormey William
, Sherlock Mark
, Thompson Chris
Severe hyponatraemia (SHN, <120 mmol/l) is reported to be associated with mortality as high as 50%; although there are several international guidelines for management of SHN, there are few data on the impact of treatment. We have longitudinally audited our treatment outcomes of SHN. We present the results of three audit periods, of six months each, from 2005, 2010 and 2015. The three periods represented; 2005, prior to hospital policy for SHN, 2010, audit of impact of poli...